Lakeview Clinical Research

Menu
Volunteer

Help us learn more about RSV vaccination

Those who qualify may receive:

  • Study-related care from local doctors at no cost
  • Reimbursement for study-related travel
  • Study vaccines at no cost

There is no obligation, so see if you may qualify now.

REGISTER TODAY

DID YOU KNOW

RSV can lead to older adults becoming very ill. This clinical research study also aims to learn more about a potential new vaccine for respiratory syncytial virus infection in adults 70 years of age or older.

RSV infects the lungs, nose, throat and breathing passages, and causes common cold-like symptoms. Both RSV infection and pneumococcal disease peak during the winter season. RSV can infect people of all ages including older adults, who may develop serious complications leading to hospitalization.

If you choose to take part in the study, you will be randomly assigned to either Group 1 or Group 2.

  • If you are in Group 1, you will receive the pneumonia vaccine (PCV20) and the investigational RSV vaccine on the same day. You will be in the study for 6 months. You will have 2 study center visits and 1 phone call.
  • If you are in Group 2, you will receive the pneumonia vaccine (PCV20) first (Day 1) and the investigational RSV vaccine 30 days later (Day 31). You will be in the study for 7 months. You will have 3 study center visits and 1 phone call.

 Participants will receive compensation after each completed visit.

REQUIREMENTS TO PARTICIPATE

  • are 70 years of age or older
  • are in good physical health
  • have not received an approved pneumococcal vaccine or investigational RSV vaccine.

Our team will contact you to verify your eligiblity and answer any questions you may have.

Our team will contact you to verify your eligiblity and answer any questions you may have.